MedTrace Logo

Molecular and Clinical Profile of Von Willebrand Disease in Spain

NCT02869074 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 790

Last updated 2025-03-12

No results posted yet for this study

Summary

The present Project is a third phase of the previous PCM-EVW-ES Project (Batlle et al. Thromb \& Haemost 2015) with the aim of its extension, further analysis with an innovation development in the field of von Willebrand disease (VWD) based in the newer recently available methodologies. The aim of this project is to help the physician in a more uniform characterization and therapy of VWD in clinical practice, at an international level. A reduction of the expenses in the diagnosis process by using the new methodologies is pursued.

Conditions

  • Von Willebrand Disease

Interventions

GENETIC

VWF gene analysis

52 exons adjacent intronic regions and promotor of VWF will be analyzed

Sponsors & Collaborators

  • Francisco Vidal Pérez

    collaborator UNKNOWN

  • Maria Fernanda López Fernández

    collaborator UNKNOWN

  • Almudena Pérez Rodríguez

    collaborator UNKNOWN

  • Irene Corrales Insa

    collaborator UNKNOWN

  • Ana Rosa Cid Haro

    collaborator UNKNOWN

  • Spanish Society of Thrombosis and Haemostasis

    lead OTHER

Principal Investigators

  • Francisco Javier BATLLE, PhD, MD · Complexo Hospitalario Universitario A Coruña. INIBIC. A Coruña. Spain

Eligibility

Min Age
2 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-03
Primary Completion
2021-09-25
Completion
2021-09-25

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02869074 on ClinicalTrials.gov